课题基金 / 基金详情

Emory Alzheimer's Disease Research Center

Emory Alzheimer's Disease Research Center
埃默里阿尔茨海默病研究中心
批准号:
10212237
负责人:
DAVID WEINSHENKER
金额:
$15.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-07-15 至 2025-04-30

项目摘要

项目成果

DAVID WEINSHENKER的其他基金

相似基金

相关文献

中文摘要
翻译
摘要/摘要:研究教育组成部分 阿尔茨海默病(AD)是导致痴呆症的最常见原因,影响着500多万美国人。在… 在AD患病率上升的同时,美国新的调查人员数量 减少,这可能严重阻碍我们努力开发更好的AD和 相关痴呆(ADRD)。Goizueta的研究教育部分(REC)的目标 埃默里阿尔茨海默氏症研究中心(ADRC)将支持以下研究教育活动 补充和加强对未来劳动力的培训,以满足国家的生物医学、行为和 ADRD的临床需求。我们将通过确定和支持初中学生的研究性教育来实现这一目标 来自不同背景和学科的调查人员和受训人员。在目标1中,REC领导力和导师 将与这些学员合作,为新的和早期阶段制定和执行量身定做的教育计划 调查人员在进行AD相关研究方面走向独立。在目标2中,我们将利用 埃默里拥有丰富的基础和临床科学家以及亚特兰大地区的合作机构,以识别、招聘和 支持对来自不同背景的新/早期调查人员和受训人员进行研究培训,并 各学科,特别是URM,从事AD相关研究。在Aim 3中,REC领导层 和外部咨询委员会将严格监督和评估学员、导师和整体 计划,并在必要时实施改进。区域经济共同体的成功将导致一批 专注于多样性的新研究人员将领导下一代ADRD研究。
英文摘要
SUMMARY/ABSTRACT: RESEARCH EDUCATION COMPONENT Alzheimer’s disease (AD) is the most common cause of dementia, affecting more than 5 million Americans. At the same time that the prevalence of AD is increasing, the number of new investigators in the US is decreasing, which may severely hamper our efforts to develop better diagnostic and treatment tools for AD and related dementias (ADRD). The goal of the Research Education Component (REC) of the Goizueta Alzheimer’s Disease Research Center (ADRC) at Emory is to support research educational activities that complement and enhance the training of the future workforce to meet the nation’s biomedical, behavioral and clinical needs in ADRD. We will achieve this goal by identifying and supporting the research education of junior investigators and trainees from diverse backgrounds and disciplines. In Aim 1, REC leadership and mentors will work with these trainees to develop and execute tailored educational plans for new and early stage investigators to advance towards independence in conducting AD-related research. In Aim 2, we will leverage Emory’s wealth of basic and clinical scientists as well as partner Atlanta-area institutions to identify, recruit and support the research training of new/early stage investigators and trainees from diverse backgrounds and disciplines, with special emphasis on URMs, to engage in AD-related research. In Aim 3, the REC leadership and external advisory committee will rigorously monitor and evaluate the trainees, mentors, and the overall program, and implement improvements when necessary. Success of the REC will result in rolling cohorts of new investigators with a focus on diversity to lead the next generation of ADRD research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Contribution of neuromelanin to selective vulnerability of locus coeruleus neurons in Alzheimer's disease
  • 批准号:
    10525513
  • 项目类别:
  • 资助金额:
    $153.16万
  • 财政年份:
    2022
  • 负责人:
    DAVID WEINSHENKER
  • 依托单位:
Contribution of locus coeruleus-derived galanin to opioid reward and reinforcement
  • 批准号:
    9981143
  • 项目类别:
  • 资助金额:
    $47.19万
  • 财政年份:
    2020
  • 负责人:
    DAVID WEINSHENKER
  • 依托单位:
Contribution of locus coeruleus-derived galanin to opioid reward and reinforcement
  • 批准号:
    10456900
  • 项目类别:
  • 资助金额:
    $46.38万
  • 财政年份:
    2020
  • 负责人:
    DAVID WEINSHENKER
  • 依托单位:
Contribution of locus coeruleus-derived galanin to opioid reward and reinforcement
  • 批准号:
    10669138
  • 项目类别:
  • 资助金额:
    $46.38万
  • 财政年份:
    2020
  • 负责人:
    DAVID WEINSHENKER
  • 依托单位:
海外基金